Serum-free culture conditions for the generation of dendritic cells from cord blood CD34+ hematopoietic progenitors: phenotypic and functional analysis

Increasing pre-clinical and clinical data suggest the efficiency of dendritic cells (DCs) in cancer immunotherapy. Relapse after cord blood hematopoietic progenitors (CBHP) transplantation is an unresolved problem. DCs obtained from CBHP could be an interesting tool for relapse treatments, but the l...

Descripción completa

Detalles Bibliográficos
Autores: Domènech Estévez, Enric, Villén, Esther, González Barca, Eva, Querol Giner, Sergi, García, Joan, Rueda, Fèlix, 1951-
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2000
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/172717
Acceso en línea:https://hdl.handle.net/2445/172717
Access Level:acceso abierto
Palabra clave:Antígens
Cèl·lules dendrítiques
Citologia
Immunologia
Antigens
Dendritic cells
Cytology
Immunology
Descripción
Sumario:Increasing pre-clinical and clinical data suggest the efficiency of dendritic cells (DCs) in cancer immunotherapy. Relapse after cord blood hematopoietic progenitors (CBHP) transplantation is an unresolved problem. DCs obtained from CBHP could be an interesting tool for relapse treatments, but the low number of CBHP hinder their use for DC generation.

Similares en LA Referencia